Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,48 USD | -3,33% | -4,13% | -84,16% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 50 | 14/07/21 | |
Director of Finance/CFO | 69 | 11/01 | |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Doug Randall
COO | Chief Operating Officer | - | 14/11/13 |
Douglas Hay
LAW | General Counsel | - | 14/11/13 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gerry Proehl
CHM | Chairman | 65 | 04/04/14 |
June Almenoff
BRD | Director/Board Member | 67 | 25/02/21 |
Declan Doogan
BRD | Director/Board Member | 72 | 25/02/21 |
Michael Davidson
BRD | Director/Board Member | 67 | 25/02/21 |
Robyn Hunter
BRD | Director/Board Member | 62 | 28/01/22 |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Chief Executive Officer | 50 | 14/07/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 210 | 0 | 0 | 99,65 % |
Azione B | 1 | 1 958 245 | 1 951 298 ( 99,65 %) | 0 |
Coordinate società
Tenax Therapeutics, Inc.
101 Glen Lennox Drive Suite 300
27517, Chapel Hill
+919 855 2100
http://www.tenaxthera.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-84,16% | 6,81 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione TENX
- Società Tenax Therapeutics, Inc.